# Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy

> **NCT00756041** · PHASE2 · TERMINATED · sponsor: **Takeda** · enrollment: 221 (actual)

## Conditions studied

- Diabetic Neuropathies

## Interventions

- **DRUG:** TAK-128

## Key facts

- **NCT ID:** NCT00756041
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-09
- **Primary completion:** 2006-09
- **Final completion:** 2006-09
- **Target enrollment:** 221 (ACTUAL)
- **Why stopped:** Lack of Efficacy.
- **Last updated:** 2012-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00756041

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00756041, "Safety Study of TAK-128 in Subjects With Diabetic Peripheral Neuropathy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00756041. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*